Skip to main content
Log in

Intragastric satiety-inducing device reduces food intake and suppresses body weight gain in a rodent model

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

An intragastric satiety-inducing device (ISD) (Full Sense Device; Baker, Foote, Kemmeter, Walburn, LLC, Grand Rapids, MI) is a novel weight-loss device, which may induce satiety by applying continuous pressure on the gastric cardia. This study investigated the effect of the ISD on food intake and body weight gain in a rodent model.

Methods

Thirty-two male Sprague–Dawley rats (weight, 250–300 g) were randomly divided into four groups of eight individuals. Single-disk (SD) and double-disk (DD) group animals underwent peroral placement of a single- or double-disk ISD, respectively, under fluoroscopic guidance. The ISD comprised a 4 mm × 1.5 cm nitinol stent placed in the lower esophagus and one (single-disk) or two (double-disk) 2.5-cm-diameter star-shaped nitinol disks placed in the gastric fundus. Esophageal stent (ES) and sham-operated (SO) group animals underwent peroral placement of the ES part of the ISD and a sham operation, respectively.

Results

Food intake was significantly different among the four groups over the 4-week study period (P < 0.001); food intake was significantly lower in the SD and DD groups than in the SO group (P = 0.016 and P = 0.002, respectively) but was not significantly different between the SD and DD groups (P > 0.999) and between the ES and SO groups (P = 0.677). Body weight was significantly different among the four groups by the end of the study period (P < 0.001); body weight was significantly lower in the DD group than in the SD, ES, and SO groups (P = 0.010, P < 0.001, and P < 0.001, respectively) and in the SD group than in the SO group (P = 0.001), but it was not significantly different between the ES and SO groups (P = 0.344).

Conclusion

ISD reduced food intake and suppressed body weight gain in a rodent model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

BMI:

Body mass index

ISD:

Intragastric satiety-inducing device

SD:

Single-disk

DD:

Double-disk

ES:

Esophageal stent

SO:

Sham-operated

References

  1. World Health Organization. Obesity and overweight: fact sheet. 2018 [updated 2018 February 16; cited 2019 July 28] Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

  2. Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1211–1259

    Article  Google Scholar 

  3. Yanovski SZ, Yanovski JA (2014) Long-term drug treatment for obesity: a systematic and clinical review. JAMA 311:74–86

    Article  CAS  Google Scholar 

  4. Maciejewski ML, Arterburn DE, Van Scoyoc L, Smith VA, Yancy WS Jr, Weidenbacher HJ, Livingston EH, Olsen MK (2016) Bariatric surgery and long-term durability of weight loss. JAMA Surg 151:1046–1055

    Article  Google Scholar 

  5. Lee PC, Dixon J (2017) Medical devices for the treatment of obesity. Nat Rev Gastroenterol Hepatol 14:553

    Article  Google Scholar 

  6. Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S, Kumar N, Larsen M, Sullivan S, Thompson CC, Banerjee S (2015) Endoscopic bariatric therapies. Gastrointest Endosc 81:1073–1086

    Article  Google Scholar 

  7. Myall P. New endoscopic stent can lead to 100% EWL. [updated 2012 June 5; cited 2019 July 28] Available from: https://www.bariatricnews.net/?q=node/102.

  8. Dayyeh BKA, Edmundowicz S, Thompson CC (2017) Clinical practice update: expert review on endoscopic bariatric therapies. Gastroenterology 152:716–729

    Article  Google Scholar 

  9. Camilleri M (2015) Peripheral mechanisms in appetite regulation. Gastroenterology 148:1219–1233

    Article  CAS  Google Scholar 

  10. Tanaka-Shintani M, Watanabe M (2005) Distribution of ghrelin-immunoreactive cells in human gastric mucosa: comparison with that of parietal cells. J Gastroenterol 40:345–349

    Article  CAS  Google Scholar 

  11. Vitari F, Di Giancamillo A, Deponti D, Carollo V, Domeneghini C (2012) Distribution of ghrelin-producing cells in the gastrointestinal tract of pigs at different ages. Vet Res Commun 36:71–80

    Article  Google Scholar 

  12. Goitein D, Lederfein D, Tzioni R, Berkenstadt H, Venturero M, Rubin M (2012) Mapping of ghrelin gene expression and cell distribution in the stomach of morbidly obese patients–a possible guide for efficient sleeve gastrectomy construction. Obes Surg 22:617–622

    Article  Google Scholar 

  13. Park JH, Bakheet N, Na HK, Jeon JY, Yoon SH, Kim KY, Zhe W, Kim DH, Jung HY, Song HY (2019) A novel full sense device to treat obesity in a porcine model: preliminary results. Obes Surg 29:1521–1527

    Article  Google Scholar 

  14. Yang J, Siddiqui AA, Kowalski TE, Loren DE, Khalid A, Soomro A, Mazhar SM, Rose J, Isby L, Kahaleh M, Kalra A, Sarkisian AM, Kumta NA, Nieto J, Sharaiha RZ (2017) Esophageal stent fixation with endoscopic suturing device improves clinical outcomes and reduces complications in patients with locally advanced esophageal cancer prior to neoadjuvant therapy: a large multicenter experience. Surg Endosc 31:1414–1419

    Article  Google Scholar 

  15. Musani AI, Jensen K, Mitchell JD, Weyant M, Garces K, Hsia D (2012) Novel use of a percutaneous endoscopic gastrostomy tube fastener for securing silicone tracheal stents in patients with benign proximal airway obstruction. J Bronchol Interv Pulmonol 19:121–125

    Article  Google Scholar 

  16. Bradley D, Magkos F, Klein S (2012) Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology 143:897–912

    Article  CAS  Google Scholar 

  17. Acosta A, Abu Dayyeh BK, Port JD, Camilleri M (2014) Recent advances in clinical practice challenges and opportunities in the management of obesity. Gut 63:687–695

    Article  CAS  Google Scholar 

  18. Orellana ER, Covasa M, Hajnal A (2019) Neuro-hormonal mechanisms underlying changes in reward related behaviors following weight loss surgery: potential pharmacological targets. Biochem Pharmacol 164:106–114

    Article  CAS  Google Scholar 

  19. Cummings DE, Shannon MH (2003) Roles for ghrelin in the regulation of appetite and body weight. Arch Surg 138(4):389–396

    Article  CAS  Google Scholar 

  20. Strader AD, Woods SC (2005) Gastrointestinal hormones and food intake. Gastroenterology 128:175–191

    Article  CAS  Google Scholar 

  21. Cummings DE, Shannon MH (2003) Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab 88:2999–3002

    Article  CAS  Google Scholar 

  22. Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, Proietto J (2011) Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 365:1597–1604

    Article  CAS  Google Scholar 

  23. Gribble FM, Reimann F (2019) Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocrinol 15:226–237

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported by a grant from the National Key R&D Program of China (grant No. 2017YFC0107800 to X.L.) and a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, and Republic of Korea (grant No. HI18C0631 to H.Y.J.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jiaywei Tsauo.

Ethics declarations

Disclosures

Yingen Luo, Xiaowu Zhang, Jiaywei Tsauo, Hwoon-Yong Jung, Ho-Young Song, He Zhao, Jingui Li, Tao Gong, Peng Song, and Xiao Li have no conflicts of interest or financial ties to disclose.

Ethical approval

All applicable institutional and/or national guidelines for the care and use of animals were followed.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, Y., Zhang, X., Tsauo, J. et al. Intragastric satiety-inducing device reduces food intake and suppresses body weight gain in a rodent model. Surg Endosc 35, 1052–1057 (2021). https://doi.org/10.1007/s00464-020-07467-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-020-07467-x

Keywords

Navigation